BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12547707)

  • 1. Renal angiomyolipomas from patients with sporadic lymphangiomyomatosis contain both neoplastic and non-neoplastic vascular structures.
    Karbowniczek M; Yu J; Henske EP
    Am J Pathol; 2003 Feb; 162(2):491-500. PubMed ID: 12547707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis.
    Smolarek TA; Wessner LL; McCormack FX; Mylet JC; Menon AG; Henske EP
    Am J Hum Genet; 1998 Apr; 62(4):810-5. PubMed ID: 9529362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis.
    Yu J; Astrinidis A; Henske EP
    Am J Respir Crit Care Med; 2001 Oct; 164(8 Pt 1):1537-40. PubMed ID: 11704609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent [corrected] hyperphosphorylation of ribosomal protein S6 [corrected] in lymphangioleiomyomatosis-associated angiomyolipomas.
    Robb VA; Astrinidis A; Henske EP
    Mod Pathol; 2006 Jun; 19(6):839-46. PubMed ID: 16575396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas.
    Henske EP; Neumann HP; Scheithauer BW; Herbst EW; Short MP; Kwiatkowski DJ
    Genes Chromosomes Cancer; 1995 Aug; 13(4):295-8. PubMed ID: 7547639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development.
    Giannikou K; Malinowska IA; Pugh TJ; Yan R; Tseng YY; Oh C; Kim J; Tyburczy ME; Chekaluk Y; Liu Y; Alesi N; Finlay GA; Wu CL; Signoretti S; Meyerson M; Getz G; Boehm JS; Henske EP; Kwiatkowski DJ
    PLoS Genet; 2016 Aug; 12(8):e1006242. PubMed ID: 27494029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constant allelic alteration on chromosome 16p (TSC2 gene) in perivascular epithelioid cell tumour (PEComa): genetic evidence for the relationship of PEComa with angiomyolipoma.
    Pan CC; Chung MY; Ng KF; Liu CY; Wang JS; Chai CY; Huang SH; Chen PC; Ho DM
    J Pathol; 2008 Feb; 214(3):387-93. PubMed ID: 18085521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis.
    Astrinidis A; Khare L; Carsillo T; Smolarek T; Au KS; Northrup H; Henske EP
    J Med Genet; 2000 Jan; 37(1):55-7. PubMed ID: 10633137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex.
    Al-Saleem T; Wessner LL; Scheithauer BW; Patterson K; Roach ES; Dreyer SJ; Fujikawa K; Bjornsson J; Bernstein J; Henske EP
    Cancer; 1998 Nov; 83(10):2208-16. PubMed ID: 9827727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal angiomyolipoma (AML) harboring a missense mutation of
    Idogawa M; Hida T; Tanaka T; Ohira N; Tange S; Sasaki Y; Uhara H; Masumori N; Tokino T; Natori H
    Cancer Biol Ther; 2020 Apr; 21(4):315-319. PubMed ID: 31847710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways.
    Yu J; Astrinidis A; Howard S; Henske EP
    Am J Physiol Lung Cell Mol Physiol; 2004 Apr; 286(4):L694-700. PubMed ID: 12922981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis.
    Carsillo T; Astrinidis A; Henske EP
    Proc Natl Acad Sci U S A; 2000 May; 97(11):6085-90. PubMed ID: 10823953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM).
    Goncharova EA; Goncharov DA; Eszterhas A; Hunter DS; Glassberg MK; Yeung RS; Walker CL; Noonan D; Kwiatkowski DJ; Chou MM; Panettieri RA; Krymskaya VP
    J Biol Chem; 2002 Aug; 277(34):30958-67. PubMed ID: 12045200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors.
    Henske EP; Wessner LL; Golden J; Scheithauer BW; Vortmeyer AO; Zhuang Z; Klein-Szanto AJ; Kwiatkowski DJ; Yeung RS
    Am J Pathol; 1997 Dec; 151(6):1639-47. PubMed ID: 9403714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma.
    El-Hashemite N; Zhang H; Henske EP; Kwiatkowski DJ
    Lancet; 2003 Apr; 361(9366):1348-9. PubMed ID: 12711473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis.
    Sato T; Seyama K; Fujii H; Maruyama H; Setoguchi Y; Iwakami S; Fukuchi Y; Hino O
    J Hum Genet; 2002; 47(1):20-8. PubMed ID: 11829138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TSC-2 product tuberin is expressed in lymphangioleiomyomatosis and angiomyolipoma.
    Johnson SR; Clelland CA; Ronan J; Tattersfield AE; Knox AJ
    Histopathology; 2002 May; 40(5):458-63. PubMed ID: 12010366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism.
    Karbowniczek M; Astrinidis A; Balsara BR; Testa JR; Lium JH; Colby TV; McCormack FX; Henske EP
    Am J Respir Crit Care Med; 2003 Apr; 167(7):976-82. PubMed ID: 12411287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of gene expression array in TSC2-deficient AML cells reveals IRF7 as a pivotal factor in the Rheb/mTOR pathway.
    Makovski V; Jacob-Hirsch J; Gefen-Dor C; Shai B; Ehrlich M; Rechavi G; Kloog Y
    Cell Death Dis; 2014 Dec; 5(12):e1557. PubMed ID: 25476905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms.
    Kenerson H; Folpe AL; Takayama TK; Yeung RS
    Hum Pathol; 2007 Sep; 38(9):1361-71. PubMed ID: 17521703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.